FILE – A pharmacist holds a vial of lenacapavir, an injectable HIV prevention drug, at the Desmond … More Tutu Health Foundation’s Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, 2024, which was one of the sites for Gilead’s lenacapavir drug trial. (AP Photo/Nardus…
